CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-20 | TZIANABOS ARTHUR Interim Executive Chair | Grant or award · Stock Option (Right to Buy) | +122,651 | 122,651 | ||
| 2025-03-20 | Leggett Thomas Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +89,000 | 89,000 | ||
| 2025-03-20 | Leggett Thomas Chief Financial Officer | Grant or award · Restricted Stock Units | +59,000 | 59,000 | ||
| 2025-03-20 | Kaye Edward M. MD Director | Grant or award · Employee Stock Option (Right to Buy) | +216,000 | 216,000 | ||
| 2025-03-20 | Kaye Edward M. MD Director | Grant or award · Restricted Stock Units | +144,000 | 144,000 | ||
| 2025-03-20 | Ticho Barry CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +64,000 | 64,000 | ||
| 2025-03-20 | Ticho Barry CHIEF MEDICAL OFFICER | Grant or award · Restricted Stock Units | +43,000 | 43,000 | ||
| 2025-03-20 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Grant or award · Employee Stock Option (Right to Buy) | +72,000 | 72,000 | ||
| 2025-03-20 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Grant or award · Restricted Stock Units | +48,000 | 48,000 | ||
| 2025-03-19 | LEVIN ARTHUR A Director | Grant or award · Restricted Stock Units | +4,842 | 4,842 | ||
| 2025-03-19 | Kaye Edward M. MD Director | Sale | −8,907 | $8.27 | $74K | 139,346 |
| 2025-03-19 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | −3,333 | $8.27 | $28K | 60,629 |
| 2025-03-19 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −1,945 | $8.27 | $16K | 31,565 |
| 2025-03-18 | Kaye Edward M. MD Director | Sale | −10,382 | $8.67 | $90K | 148,253 |
| 2025-03-18 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | −3,884 | $8.67 | $34K | 63,962 |
| 2025-03-18 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −2,266 | $8.67 | $20K | 33,510 |
| 2025-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise | +7,475 | 29,776 | ||
| 2025-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise | +6,000 | 35,776 | ||
| 2025-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Restricted Stock Units | −7,475 | 14,950 | ||
| 2025-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Restricted Stock Units | −6,000 | 18,000 |
Page 12 of 13 · 256 trades